General Cancer News
Top Stories
Feds Report First Overall Cancer Decline In Years: Improved Testing, Tobacco Control And Education Credited
POSTED: November 25, 2008For the first time in a decade of reporting trends in cancer incidence and deaths, the National Cancer Institute says there is an overall decline in both. Incidence of all cancers dropped almost 1 percent a year from 1999 through 2005 and death rates dropped 1.8 percent each year from 2002 to 2005. Some key drivers of the decrease include:...
Study Suggests Some Breast Cancers May Resolve Without Treatment
POSTED: November 25, 2008TORONTO -- A significant portion of invasive breast cancers may regress on their own without treatment, a new study that is bound to provoke controversy suggests. The study, published Monday in the journal Archives of Internal Medicine, suggested breast cancer screening may be leading to over diagnosis of cancer, with about 22 percent of cases likely...
Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer
POSTED: November 25, 2008SOUTH SAN FRANCISCO, Calif. -- Genentech, Inc. (NYSE:DNA) today announced that a Phase III study (RIBBON 1) of Avastin(R) (bevacizumab), in combination with taxane, anthracycline-based or capecitabine chemotherapies for first-line treatment of metastatic HER2-negative breast cancer, met its primary endpoint of increasing the time patients lived ...
Curbing Stress May Cut Cancer Risk / Counseling Methods Said To Boost Survival; Some Experts Express Doubts
POSTED: November 25, 2008Psychological counseling, muscle relaxation and other strategies for reducing stress in breast-cancer patients can cut their risk of death from the disease by more than one-half, according to a study published online yesterday in the journal Cancer. The study also found that psychological interventions reduced the risk that the tumors would c...
Pioneering Research Improves Accuracy Of Colorectal Cancer Staging
POSTED: November 25, 2008SANTA MONICA, Calif. -- Results of a pioneering study led by researchers at the John Wayne Cancer Institute at Saint John's Health Center show that sensitive molecular diagnostic techniques can effectively upstage early stage colorectal cancer patients believed to be cancer-free according to conventional methods. The findings could lead to more ...
NCCN Receives $1.5 Million Grant To Research Targeted Therapy In Bladder Cancer
POSTED: November 25, 2008FORT WASHINGTON, Pa. -- The National Comprehensive Cancer Network (NCCN), Bristol-Myers Squibb Company and ImClone Systems Incorporated have entered into a collaboration to conduct a multi-institutional, investigator-initiated study in bladder cancer using cetuximab (ERBITUX(R), Bristol-Myers Squibb Company/ImClone Systems Incorporated). The U...
Researchers Say Identification Of Women With HPV Types 16, 18 And 45 Could Improve Early Intervention To Stop Cervical Cancer
POSTED: November 25, 2008As testing for high-risk types of the human papillomavirus (HPV) emerges as the gold standard in cervical cancer prevention, scientists are already researching how to determine even more precisely who is most likely to develop the disease and thus are in need of more immediate intervention. Speaking at the EUROGIN (European Research Organization on Geni...
U.S. FDA Grants Pralatrexate Orphan Drug Designation For The Treatment Of Patients With Diffuse Large B-cell Lymphoma
POSTED: November 25, 2008WESTMINSTER, Colo. -- Allos Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to the Company's novel antifolate, pralatrexate (PDX), for the tr...
TargetScan Evaluation Is Shown To Deliver Potentially Higher Cancer Detection Rate And More Accurate Assessment Of Grade-more Accurate Diagnosis Can Lead To Earlier Treatment
POSTED: November 25, 2008ST. LOUIS -- A study released recently in the British Journal of Urology detailed the results from biopsies of 140 men who received care at Washington University in St. Louis, Duke University, and the University of Michigan. The study, titled "Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer," found tha...
Genomic Health Announces Publication Of A Study Demonstrating The Oncotype DX Breast Cancer Assay Influences Chemotherapy Treatment Recommendation In 44 Percent Of Patients Evaluated
POSTED: November 22, 2008Genomic Health, Inc. announced the publication of results from a study indicating that Oncotype DX(R) Recurrence Score(R) results impact the way physicians treat early-stage breast cancer. The study, published in the October issue of the American Journal of Surgery, showed that treatment changed as a result of Oncotype DX in 44 percent of patients with ...
